- Home
- GDEN vs AGMB Comparison
GDEN vs AGMB Comparison
Compare GDEN & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | AGMB |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | Belgium |
| Employees | 504 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.2M | 677.9M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDEN | AGMB |
|---|---|---|
| Price | $28.53 | $10.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $32.25 | $32.00 |
| AVG Volume (30 Days) | ★ 311.8K | 166.9K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $634,911,000.00 | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.87 | $17.86 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.57 | $9.00 |
| 52 Week High | $32.74 | $17.45 |
Technical Indicators
Market Signals| Indicator | GDEN | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 60.63 | 43.51 |
| Support Level | $28.30 | $9.91 |
| Resistance Level | $28.78 | $11.99 |
| Average True Range (ATR) | 0.39 | 0.94 |
| MACD | 0.07 | 0.17 |
| Stochastic Oscillator | 75.90 | 44.11 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.